company info

company info

company info

Name Genome Pharmaceuticals Institute Co., Ltd.
Founded Dec. 21, 2000
Capital
 31,370,000 yen
Our Business

Purpose
A bio-venture company of cooperation between industry and academia. And that is established to rely on research of Professor Sekimizu of University of Tokyo to put into practical use.

Area
1．To develop antibiotics
2．To develop functional health foods using innate stimulant index, and its entrusted business
3．To develop disease models using silkworm, and its entrusted business
Place *head office 1-27-8-1207 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
*lab. & office 401 University of Tokyo Entrepreneur Plaza, 7-3-1 Hongo,
Bunkyo-ku, Tokyo 113-0033, Japan
Tel: +81 3 5684 8570
http://www.ducr.u-tokyo.ac.jp/en/access.html

Corporate History

December 2000 Founded as limited company
April        2001 Started business with Japanese major pharmaceutical company based on collaborative research agreement
March       2005 Capitalized by NIF ventures Co., Ltd.
May         2005 Opened Wet Lab. at sotokanda, chiyoda-ku, Tokyo
May         2005 Reorganized and incorporated. Company name changed to
Genome Pharmaceuticals Institute Co., Ltd.
July         2007 Joined to the basic research by National Institute of Biomedical
Innovation as an implementation institute
（研究プロジェクト名：カイコ幼虫感染症モデルを用いた、バイオアッセ
イによる感染症治療薬シーズの開発）
August      2007 Moved to University of Tokyo Entrepreneur Plaza, Hongo, Bunkyo-ku, Tokyo
July        2008 Our theme was selected for “Practical Application of the Results of Innovative Research by Universities and other Institutions” by Japan Science and Technology Agency (JST)
研究課題名：カイコをテスターとする、農産物、食品、並びに環境の毒性・病原性試験法の開発